Radioembolisation vs sorafenib monotherapy
Disease control rate · people with hepatocellular carcinoma
It is very uncertain whether radioembolisation changes disease control rate compared with sorafenib (very low certainty).
1 finding from 1 review
- Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma 2020 · Cochrane Headline outcomes onlyRR 0.94 [0.84, 1.05]2 studies · 748 participantsVery low